Published in Lipids Health Dis on December 06, 2014
The Possible Role of Flavonoids in the Prevention of Diabetic Complications. Nutrients (2016) 0.81
The protective effects of oral low-dose quercetin on diabetic nephropathy in hypercholesterolemic mice. Front Physiol (2015) 0.79
Combinatorial effects of quercetin and sex-steroids on fluid and electrolytes' (Na+, Cl-, HCO3-) secretory mechanisms in the uterus of ovariectomised female Sprague-Dawley rats. PLoS One (2017) 0.75
Involvement of the NF-κB signaling pathway in the renoprotective effects of isorhamnetin in a type 2 diabetic rat model. Biomed Rep (2016) 0.75
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects. Int J Mol Sci (2016) 0.75
Oxidative stress, antioxidants and intestinal calcium absorption. World J Gastroenterol (2017) 0.75
Resin from Virola oleifera Protects Against Radiocontrast-Induced Nephropathy in Mice. PLoS One (2015) 0.75
Short-term High Dose of Quercetin and Resveratrol Alters Aging Markers in Human Kidney Cells. Int J Prev Med (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA (2002) 8.81
Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science (1976) 4.08
Mouse models of diabetic nephropathy. J Am Soc Nephrol (2004) 3.95
Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest (2001) 3.46
Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol (2008) 2.78
The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes (1983) 2.56
Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med (1989) 2.21
Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol (2005) 2.18
Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) (2007) 1.88
Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol (2003) 1.86
Diabetic nephropathy and antioxidants. J Nephropathol (2013) 1.80
Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care (2008) 1.58
Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia (2001) 1.53
Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J (2006) 1.53
Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am J Physiol Renal Physiol (2012) 1.51
AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol (2007) 1.49
Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol Pharm Bull (2003) 1.34
Oxidative stress and diabetic kidney disease. Curr Diab Rep (2011) 1.32
Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep (2009) 1.28
Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One (2012) 1.21
Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol (2009) 1.19
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products. J Am Soc Nephrol (2004) 1.15
Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res (2013) 1.14
Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. J Nutr Sci Vitaminol (Tokyo) (2007) 1.13
Antidiabetic effect of Phlomis anisodonta: effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Pharmacol Res (2007) 1.13
Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol (2004) 1.12
Microvascular complications of diabetes mellitus: renal protection accompanies cardiovascular protection. Am J Cardiol (2008) 1.11
Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract (2011) 1.09
Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol Nutr Food Res (2009) 1.07
The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. Diabetes (2006) 1.05
Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int (2000) 1.05
Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr Res Pract (2012) 1.05
Mitochondrial dysfunction and complications associated with diabetes. Biochim Biophys Acta (2013) 1.04
Relaxation to flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure-activity relationships. J Cardiovasc Pharmacol (2000) 1.03
Protective role of quercetin against lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and NF-κB pathway. Biochim Biophys Acta (2012) 1.03
Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis (2010) 1.01
Role of dietary and endogenous antioxidants in diabetes. Crit Rev Food Sci Nutr (2014) 1.00
Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse. J Biomed Sci (2012) 0.99
Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4'-glucoside. J Nutr (2001) 0.99
Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice. Arch Med Res (2007) 0.98
Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci (2014) 0.98
Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr Diabetes Rev (2011) 0.94
New targets for treatment of diabetic nephropathy: what we have learned from animal models. Curr Opin Nephrol Hypertens (2013) 0.92
Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin-induced diabetic rat testis. Food Chem Toxicol (2011) 0.91
Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J Cardiovasc Pharmacol (2005) 0.91
Quercetin protects rat liver against lead-induced oxidative stress and apoptosis. Environ Toxicol Pharmacol (2010) 0.91
Extent and persistence of streptozotocin-induced DNA damage and cell proliferation in rat kidney as determined by in vivo alkaline elution and BrdUrd labeling assays. Toxicol Appl Pharmacol (1995) 0.91
Bioavailability of quercetin: problems and promises. Curr Med Chem (2013) 0.91
Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int J Med Sci (2014) 0.89
Quercetin protects the rat kidney against oxidative stress-mediated DNA damage and apoptosis induced by lead. Environ Toxicol Pharmacol (2010) 0.88
DNA-protective effects of quercetin or naringenin in alloxan-induced diabetic mice. Eur J Pharmacol (2011) 0.87
Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis (2008) 0.87
Sildenafil ameliorates oxidative stress and DNA damage in the stenotic kidneys in mice with renovascular hypertension. J Transl Med (2014) 0.87
Replication-deficient adenovirus vector transfer of gfp reporter gene into supraoptic nucleus and subfornical organ neurons. Exp Neurol (1998) 0.87
Effects of Aging and Hypercholesterolemia on Oxidative Stress and DNA Damage in Bone Marrow Mononuclear Cells in Apolipoprotein E-deficient Mice. Int J Mol Sci (2013) 0.86
Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract (2005) 0.86
Evaluation of trace elements and oxidative stress levels in the liver and kidney of streptozotocin-induced experimental diabetic rat model. Gen Physiol Biophys (2011) 0.85
Stabilization of quercetin paradoxically reduces its proapoptotic effect on UVB-irradiated human keratinocytes. Cancer Prev Res (Phila) (2008) 0.84
Sildenafil ameliorates biomarkers of genotoxicity in an experimental model of spontaneous atherosclerosis. Lipids Health Dis (2013) 0.83
Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats. Ren Fail (2011) 0.83
The flavonoid quercetin induces changes in mitochondrial permeability by inhibiting adenine nucleotide translocase. J Bioenerg Biomembr (2009) 0.83
Protective effects of a novel sea buckthorn wine on oxidative stress and hypercholesterolemia. Food Funct (2013) 0.82
Associations between structural and functional changes to the kidney in diabetic humans and mice. Life Sci (2013) 0.82
Growth inhibition and apoptosis induction by (+)-Cyanidan-3-ol in hepatocellular carcinoma. PLoS One (2013) 0.82
DNA damage and augmented oxidative stress in bone marrow mononuclear cells from Angiotensin-dependent hypertensive mice. Int J Hypertens (2013) 0.82
Insulin attenuates diabetes-related mitochondrial alterations: a comparative study. Med Chem (2006) 0.81
Quercetin differently regulates insulin-mediated glucose transporter 4 translocation under basal and inflammatory conditions in adipocytes. Mol Nutr Food Res (2013) 0.81
Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Hum Exp Toxicol (2014) 0.80
Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice. Am J Physiol Renal Physiol (2013) 0.80
Renal protective effects of extracts from guava fruit (Psidium guajava L.) in diabetic mice. Plant Foods Hum Nutr (2012) 0.79
Pioglitazone, extract of compound Danshen dripping pill, and quercetin ameliorate diabetic nephropathy in diabetic rats. J Endocrinol Invest (2012) 0.78
Increasing the added-value of onions as a source of antioxidant flavonoids: a critical review. Crit Rev Food Sci Nutr (2014) 0.78
Influence of treatment with quercetin on lipid parameters and oxidative stress of pregnant diabetic rats. Can J Physiol Pharmacol (2013) 0.77
Outcome of acute renal injury in diabetic mice with experimental endotoxemia: role of hypoxia-inducible factor-1 α. J Diabetes Res (2013) 0.77
Free radical scavenging activity of Kielmeyera variabilis (Clusiaceae). Molecules (2013) 0.76
Management of hyperglycemia in patients with chronic kidney disease. J Nephrol (2013) 0.76
Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis (2011) 1.22
Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. Hypertension (2005) 1.07
Cardiovascular autonomic imbalance and baroreflex dysfunction in the apolipoprotein E-deficient mouse. Cell Physiol Biochem (2012) 1.02
Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis (2010) 1.01
Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse. J Biomed Sci (2012) 0.99
Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice. Arch Med Res (2007) 0.98
Evaluation of baroreflex control of heart rate in renovascular hypertensive mice. Can J Physiol Pharmacol (2007) 0.93
Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice. Lipids Health Dis (2011) 0.92
Sildenafil restores endothelial function in the apolipoprotein E knockout mouse. J Transl Med (2013) 0.92
Mononuclear cell therapy reverts cuff-induced thrombosis in apolipoprotein E-deficient mice. Lipids Health Dis (2012) 0.88
Endothelial dysfunction of resistance vessels in female apolipoprotein E-deficient mice. Lipids Health Dis (2010) 0.88
Overexpression of eNOS prevents the development of renovascular hypertension in mice. Can J Physiol Pharmacol (2008) 0.87
Sildenafil ameliorates oxidative stress and DNA damage in the stenotic kidneys in mice with renovascular hypertension. J Transl Med (2014) 0.87
Effects of Aging and Hypercholesterolemia on Oxidative Stress and DNA Damage in Bone Marrow Mononuclear Cells in Apolipoprotein E-deficient Mice. Int J Mol Sci (2013) 0.86
Cardiac-autonomic imbalance and baroreflex dysfunction in the renovascular Angiotensin-dependent hypertensive mouse. Int J Hypertens (2012) 0.85
Decreased baroreflex sensitivity in isoproterenol-treated mice with cardiac hypertrophy. Auton Neurosci (2004) 0.85
Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension. J Transl Med (2014) 0.84
Sildenafil ameliorates biomarkers of genotoxicity in an experimental model of spontaneous atherosclerosis. Lipids Health Dis (2013) 0.83
Effects of tobacco smoking during pregnancy on oxidative stress in the umbilical cord and mononuclear blood cells of neonates. J Biomed Sci (2014) 0.83
Mechanisms of enhanced vasoconstriction in the mouse model of atherosclerosis: the beneficial effects of sildenafil. Curr Pharm Biotechnol (2015) 0.83
Hypercholesterolemia promotes early renal dysfunction in apolipoprotein E-deficient mice. Lipids Health Dis (2011) 0.82
Renovascular hypertension leads to DNA damage and apoptosis in bone marrow cells. DNA Cell Biol (2013) 0.82
Granulocyte colony stimulating factor prevents kidney infarction and attenuates renovascular hypertension. Cell Physiol Biochem (2012) 0.82
DNA damage and augmented oxidative stress in bone marrow mononuclear cells from Angiotensin-dependent hypertensive mice. Int J Hypertens (2013) 0.82
The role of dyslipidemia on ocular surface, lacrimal and meibomian gland structure and function. Curr Eye Res (2012) 0.81
Effects of 5/6 nephrectomy on renal function and blood pressure in mice. Int J Physiol Pathophysiol Pharmacol (2012) 0.81
Oral P. gingivalis infection alters the vascular reactivity in healthy and spontaneously atherosclerotic mice. Lipids Health Dis (2011) 0.80
Sildenafil Improves Vascular Endothelial Structure and Function in Renovascular Hypertension. Curr Pharm Biotechnol (2015) 0.80
Experimental-induced periodontitis is exacerbated in spontaneously hypertensive rats. Clin Exp Hypertens (2005) 0.79
Effects of the local anaesthetic ropivacaine on vascular reactivity in the mouse perfused mesenteric arteries. Basic Clin Pharmacol Toxicol (2006) 0.78
Endogenous female sex hormones delay the development of renal dysfunction in apolipoprotein E-deficient mice. Lipids Health Dis (2014) 0.76
Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis. Curr Pharm Biotechnol (2016) 0.76
Hemodynamic reactivity to laboratory stressors in healthy subjects: influence of gender and family history of cardiovascular diseases. Int J Med Sci (2013) 0.75
Baroreflex control of renal sympathetic nerve activity in mice with cardiac hypertrophy. Auton Neurosci (2012) 0.75